Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year By: CNBC.com News June 21, 2024 at 15:45 PM EDT Some patients with obstructive sleep apnea and obesity who took the highest dose of Zepbound achieved "disease resolution," in the two trials. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year By: CNBC.com News June 21, 2024 at 15:45 PM EDT Some patients with obstructive sleep apnea and obesity who took the highest dose of Zepbound achieved "disease resolution," in the two trials. Read More >>